TY - JOUR
T1 - Frecuencia y distribución geográfica del uso de sacubitril/valsartán en Colombia entre los años 2019 y 2020
AU - Herrera-Leaño, Nancy
AU - Barahona-Correa, Julián E.
AU - Muñoz-Velandia, Oscar
AU - Fernández-ávila, Daniel G.
AU - García, Ángel A.
N1 - Publisher Copyright:
© 2023 Sociedad Colombiana de Cardiología y Cirugía Cardiovascular. Publicado por Permanyer.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Introduction: Real-life adherence to the management of heart failure is suboptimal. Adherence to the recommendations for the use of sacubitril/valsartan in Colombia is unknown. Objective: To assess the frequency of use, geographic distribution, and demo-graphic characteristics of patients who were prescribed sacubitril/valsartan in 2019-2020, using data from the “Sistema Integrado de Información de Protección Social” (SISPRO). Materials and method: This is a descriptive cross-sectional study. Information was extracted on the prescription distribution by department, gender, five-year age groups and the ICD-10 codes with which the medication was prescribed. Results: Between 2019 and 2020, 23,026 patients in Colombia were prescribed sacubitril/valsartan; 63.86% of the patients were men. Ninety-two percent of the prescriptions were for patients over the age of 50. The regions of the country with the highest prescription frequency were Bogotá, Sucre and Santander. Conclusions: Taking into account the estima-ted prevalence of heart failure (2-3%), the frequency with which sacubitril/valsartan is prescribed in Colombia is lower than expec-ted. The rural regions of the country have the lowest use, which suggests access barriers that should be explored.
AB - Introduction: Real-life adherence to the management of heart failure is suboptimal. Adherence to the recommendations for the use of sacubitril/valsartan in Colombia is unknown. Objective: To assess the frequency of use, geographic distribution, and demo-graphic characteristics of patients who were prescribed sacubitril/valsartan in 2019-2020, using data from the “Sistema Integrado de Información de Protección Social” (SISPRO). Materials and method: This is a descriptive cross-sectional study. Information was extracted on the prescription distribution by department, gender, five-year age groups and the ICD-10 codes with which the medication was prescribed. Results: Between 2019 and 2020, 23,026 patients in Colombia were prescribed sacubitril/valsartan; 63.86% of the patients were men. Ninety-two percent of the prescriptions were for patients over the age of 50. The regions of the country with the highest prescription frequency were Bogotá, Sucre and Santander. Conclusions: Taking into account the estima-ted prevalence of heart failure (2-3%), the frequency with which sacubitril/valsartan is prescribed in Colombia is lower than expec-ted. The rural regions of the country have the lowest use, which suggests access barriers that should be explored.
KW - Colombia
KW - Heart failure
KW - Sacubitril/valsartan
UR - http://www.scopus.com/inward/record.url?scp=85187148186&partnerID=8YFLogxK
U2 - 10.24875/RCCAR.22000008
DO - 10.24875/RCCAR.22000008
M3 - Artículo
AN - SCOPUS:85187148186
SN - 0120-5633
VL - 31
SP - 12
EP - 18
JO - Revista Colombiana de Cardiologia
JF - Revista Colombiana de Cardiologia
IS - 1
ER -